Genomics Geoff (with a J) (@GenomicG) header
Genomics Geoff (with a J) (@GenomicG) profile picture

Genomics Geoff (with a J)

@GenomicG

#illumina - Genomics padiwan.

Joined January 2021
  • Tweets160
  • Following227
  • Followers136
33Media
Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)Photo by Genomics Geoff (with a J) (@GenomicG)
Genomics Geoff (with a J) retweeted
Mike Lelivelt (@lelivelt) profile picture
Mike Lelivelt@lelivelt27 Oct 2022
Standing room only at #ASHG22 for Andrew Shaver to discuss Illumina Complete Long Reads
Image from Mike Lelivelt (@lelivelt)
6
1
40
Genomics Geoff (with a J) retweeted
Patrick Short (@patrick_j_short) profile picture
Patrick Short@patrick_j_short29 Sep 2022
$200 whole genome announced by @illumina. Machines cost $1.25m and can do 20k per year. However, What’s always struck me is how they stay ahead by solving the ‘whole problem’. not just throughout/cost but also eliminating need for refrigerating reagents, 1 box instead of 3. #IGF
6
34
5
232
Genomics Geoff (with a J) retweeted
Elli Papaemmanuil, PhD (@PapaemmanuilLab) profile picture
Elli Papaemmanuil, PhD@PapaemmanuilLab29 Sep 2022
#NovaseqX is here to produce 20,000 human WGS per year. Promise of increased accuracy + #dragen integration. List price $200 per genome. The time for bringing comprehensive clinical grade whole genome sequencing to patients is NOW. @illumina isabl.io #IGF
1
20
97
Genomics Geoff (with a J) retweeted
Anthony Beckhouse (@AntoBeck) profile picture
Anthony Beckhouse@AntoBeck29 Sep 2022
We've got a new baby #NovaSeq X and X Plus with #XLEAP-SBS..... @illumina #IGF Look at that smile on @fdesouza #genomics . 8 lanes are back baby!! With #DRAGEN on board! 20,000 WGS per year. 2.5X NovaSeq 6000.
Image from Anthony Beckhouse (@AntoBeck)
13
54
Genomics Geoff (with a J) retweeted
Gary Schroth (@Genomics_Guy) profile picture
Gary Schroth@Genomics_Guy18 Jul 2022
This is going to be so exciting! Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama prn.to/3cn0vD0
Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President...

Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President...

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that former President of the...

prnewswire.com
3
18
68
Genomics Geoff (with a J) retweeted
Eric Topol (@EricTopol) profile picture
Eric Topol
@EricTopol1 Jun 2022
The mutations our blood cells acquire as we age—clonal hematopoiesis—is the norm, 10% of blood cells for age 70+, with marked reduction of diversity; 2 landmark studies @Nature @NatureNV summary 👇 nature.com/articles/s41586-0… nature.com/articles/s41586-0… nature.com/articles/d41586-0…
Clonal dynamics of haematopoiesis across the human lifespan

Clonal dynamics of haematopoiesis across the human lifespan

Nature - Haematopoiesis has high clonal diversity up to about 65 years of age, after which diversity drops precipitously owing to positive selection acting on a handful of clones that expand...

nature.com
3
41
133
Awesome!
Andrew Kaczynski (@KFILE) profile pictureAndrew Kaczynski
@KFILE22 Mar 2022
The State Department and @StJude are helping evacuate pediatric cancer patients from Ukraine to Memphis for treatment at St. Jude. state.gov/the-evacuation-of-…
Image from Andrew Kaczynski (@KFILE)
1
Genomics Geoff (with a J) retweeted
catharine.aquino (@CatharineAquino) profile picture
catharine.aquino@CatharineAquino18 Mar 2022
Running the #novaseq @illumina is a cool job
4
4
6
53
I’ll be attending #ACMG2022 next week if anyone would like to chat on how #Illumina is taking rare disease detection to the next level.
2
3
1
12
#genetics #GCchat
Genomics Geoff (with a J) retweeted
Vanessa Moeder (@VanessaMoeder) profile picture
Vanessa Moeder@VanessaMoeder18 Jan 2022
Shameless plea for networking help (clinical ID/epi folks, please share)-> For the infectious disease leader with a passion for genomics and improving public health on a global scale, this is a once-in-a-lifetime opportunity @illumina: illumina.wd1.myworkdayjobs.c… #Genomics
1
1
1
9
Genomics Geoff (with a J) retweeted
Illumina (@illumina) profile picture
Illumina
@illumina19 Jan 2022
We will reach the $100 genome. #TweetItIntoExistence
8
45
6
206
PierianDx is hosting a webinar on “Understanding Somatic NGS Testing Guidelines for Prostate Cancer” on Jan 19th (next Wednesday). bit.ly/3nmWFN9
1
1
#illumina #chemistryX
1
10
Genomics Geoff (with a J) retweeted
Gary Schroth (@Genomics_Guy) profile picture
Gary Schroth@Genomics_Guy10 Jan 2022
New @Illumina #Infinity technology enables 10x greater throughput with 90% less DNA input than traditional long reads. #JPM2022 #JPM22
8
29
2
93
Genomics Geoff (with a J) retweeted
Merrilyn Datta, Ph.D. (@merrilyn57) profile picture
Merrilyn Datta, Ph.D.@merrilyn5710 Jan 2022
Chemistry X. That’s it. That’s the tweet. @illumina #sequencing #NGS #JPM2022
3
5
41
Chemistry X!!!
9
Genomics Geoff (with a J) retweeted
ACMG (@TheACMG) profile picture
ACMG
@TheACMG9 Jan 2022
Our letter to @nytimes editor responding to #NIPT screening article has been published. ACMG Pres-Elect Dr. Susan Klugman explains these are screening, not diagnostic, tests; more definitive tests follow positive screens, & pretest counseling is crucial. nyti.ms/3HP5LtA
Image from ACMG (@TheACMG)
40
3
75
Hypermutation and microsatellite burden determine responses & long-term survival following PD-1 blockade in children and young adults with refractory cancers resulting from germline DNA replication repair deficiency go.nature.com/3JL6TAx
A well put together e-book from @CanexiaHealth. Provides insight into the rationale behind developing local, in-house NGS testing to minimize cancer care gap that is often times drawn along socio-economic and geographic lines. bit.ly/3HIqDTh
Load more